Piek et al. presented the first clinical evidence supporting this hypothesis by identifying pre-neoplastic lesions with increased staining for p53 and Ki67 in the fallopian tubes of BRCA-positive women who are predisposed to developing ovarian carcinoma [5]. Here, TP53 is linked to ovarian carcinoma.